Earnings · China A-shares
Shanghai RAAS Blood Products Co., Ltd. Class A (002252) earnings
Shanghai RAAS Blood Products Co., Ltd. Class A published its Q3 report on 2026-10-27: net profit -33.44% year on year, -36.22% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -0.42% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-27
- Period end
- 2026-09-30
- Net profit YoY
- -33.44%
- Excl. one-offs YoY
- -36.22%
- Net profit QoQ
- -8.02%
- Result
- Bad / loss
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -0.84% | — |
| 3 days | -0.42% | — |
| 7 days | +5.26% | — |
| 14 days | -0.63% | — |
Report history
Over the last 8 reports, net profit grew year on year in 1 of them. The stock rose in the 3 trading days after 2 of 8 reports (average +0.11%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-28 | ¥978.93M | -33.44% | -36.22% | -18.83% | 0.15 | 3.01% | -0.42% | — | — |
| 2026 interim report | 2026-08-25 | ¥661.22M | -35.80% | -39.85% | -18.79% | 0.10 | 2.04% | +2.91% | +2.91% | +8.94% |
| 2026 Q1 report | 2026-04-29 | ¥315.83M | -44.21% | -43.85% | -24.75% | 0.05 | 0.97% | +0.91% | -9.24% | -10.19% |
| 2025 annual report | 2026-03-27 | ¥1.58B | -28.10% | -24.25% | -10.13% | 0.24 | 4.90% | -0.17% | -3.77% | -15.62% |
| 2025 Q3 report | 2025-10-28 | ¥1.47B | -19.97% | -14.60% | -3.54% | 0.22 | 4.55% | +0.00% | -1.34% | +2.03% |
| 2025 interim report | 2025-08-30 | ¥1.03B | -17.00% | -7.84% | -7.06% | 0.15 | 3.19% | -1.45% | -3.05% | -3.90% |
| 2025 Q1 report | 2025-04-28 | ¥566.08M | -25.20% | -3.52% | -2.45% | 0.09 | 1.76% | -0.15% | +3.42% | +0.18% |
| 2024 annual report | 2025-04-18 | ¥2.19B | +23.25% | +13.47% | +2.67% | 0.33 | 7.13% | -0.73% | +2.34% | -0.57% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.